The global demand for Epigenetics Market is presumed to reach the valuation of nearly USD 10.93 BN by 2030 from USD 2.7 BN in 2022 with a CAGR of 19.1% during the period of 2023-2030.
Epigenetics is referred to as the study of genetics that deals with stable, heritable and reversible changes in the gene expression. The changes in the gene expression does not involve any changes in the DNA sequence, however, it modifies the histones containing chromatin & DNA methylation. In epigenetics, the changes in the gene expression occurs in all developmental stages. It is used for easy and accurate diagnosis of cancer, cardiovascular diseases, neurological and metabolic disorders.
Market Dynamics
Growing prevalence of cancer and cardiovascular diseases is the driving the epigenetics market. Increasing adoption of epigenetics drugs as an alternative treatment to the conventional cancer treatment is further fueling the growth of the epigenetics market. Additionally, wide spread in application for non-oncology diseases coupled with rise in investment in research & development activities for epigenetics drugs is boosting the demand for epigenetics. However, high cost of the instruments is expected to hamper the market growth in the near future.
The report covers Porter's Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of epigenetics.
Market Segmentation
The entire epigenetics market has been sub-categorized into product, technology and application. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By Product & Service
- Kits & Reagents
- Enzymes
- Instruments and Accessories
- Software
- Service
By Method
- DNA Methylation
- Histone Modifications
- Other Methods
By Technique
- NGS
- PCR & qPCR
- Mass Spectrometry
- Sonication
- Other Techniques
By Application
- Oncology
- Metabolic Diseases
- Immunology
- Developmental Biology
- Cardiovascular Diseases
- Other Applications
By End User
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Hospitals & Clinics
Regional Analysis
This section covers regional segmentation which accentuates on current and future demand for epigenetics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Epigenetics Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Epigenetics market include Thermo Fisher Scientific (US), Merck KGaA (Germany), Illumina, Inc. (US), PacBio (US), Abcam plc (UK), Active Motif, Inc. (US) Bio-Rad Laboratories (US), Promega Corporation (US), PerkinElmer (US). Qiagen (Germany), New England Biolabs (US), Zymo Research Corporation (US), Diagenode (Germany), and F. Hoffmann-La Roche Ltd (Switzerland). This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.